MultivisionDx creates AI-driven decision-support tools for solid cancer diagnosis and treatment selection.
MultivisionDx has raised $1.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2025.
MultivisionDx's investors include Kaikarhenni Oy, Antler, University of Helsinki.
MultivisionDx is headquartered in Helsinki, Finland.
MultivisionDx creates AI-driven decision-support tools for solid cancer diagnosis and treatment selection.
MultivisionDx is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MultivisionDx — Funding & Investors." VCBacked, December 2, 2025, https://www.vcbacked.co/company/multivisiondx. Accessed July 19, 2026.
VCBacked. (2025). MultivisionDx — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/multivisiondx
{{cite web |title=MultivisionDx — Funding & Investors |url=https://www.vcbacked.co/company/multivisiondx |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated